Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University…
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University…
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts…
New Oncology from Cologne (Germany) is a biotech which today published a paper in Nature on…
The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs…
Paris based Sofinnova continues to invest in the Alzheimer's fight, with a €27.5M pot given…
Nestlé Institute of Health Sciences (NIHS) is teaming up with the Swiss AC Immune to…
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial…
AC Immune received a first milestone payment from Roche’s subsidiary Genentech. The latter picked up…
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its…
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of…
The progressive aging of the population in developed countries is turning Alzheimer into one of…
Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and…